Finance

Lists
Q9T:FRA
ME Therapeutics Holdings Inc
€1.09
0.00%
(0.00) 1D
Sep 8, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for Q9T...
Open
€1.09
High
€1.09
Low
€1.09
Mkt. cap
75.97M
Avg. vol.
0.00
Volume
0.00
52-wk high
€3.00
52-wk low
€0.74
Open
€1.09
High
€1.09
Low
€1.09
Mkt. cap
75.97M
Avg. vol.
0.00
Volume
0.00
52-wk high
€3.00
52-wk low
€0.74
News stories
From web sources and news partners
About ME Therapeutics Holdings Inc
CEO-
Employees-
Founded2014
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitemetherapeutics.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
165.08K
141.84K
178.41K
245.32K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
209.58K
213.56K
124.66K
163.76K
Operating expense
401.22K
381.91K
331.36K
436.48K
Total operating expenses
401.22K
381.91K
331.36K
436.48K
Operating income
-401.22K
-381.91K
-331.36K
-436.48K
Other non operating income
57.29K
23.69K
39.50K
35.46K
EBT including unusual items
-338.41K
-354.43K
-289.22K
-398.35K
EBT excluding unusual items
-338.41K
-354.43K
-289.22K
-398.35K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-338.41K
-354.43K
-289.22K
-398.35K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
8.34K
6.10K
4.39K
3.87K
Interest expense
-2.82K
-2.31K
-1.76K
-1.20K
Net interest expenses
5.52K
3.79K
2.63K
2.68K
Depreciation and amortization charges
26.56K
26.52K
28.28K
27.40K
EBITDA
-388.82K
-369.59K
-317.26K
-423.28K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps